Awh Capital, L.P. Ovid Therapeutics Inc. Transaction History

Awh Capital, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$2.28 - $6.84 $511,859 - $1.54 Million	-224,500 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$5.39 - $8.24 $1.21 Million - $1.85 Million	224,500 New	224,500 $1.29 Million
Q1 2020 May 15, 2020	SELL	$2.03 - $4.35 $619,149 - $1.33 Million	-305,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.08 - $5.06 $93,600 - $227,699	45,000 Added 17.31%	305,000 $1.27 Million
Q3 2019 Nov 14, 2019	BUY	$1.76 - $3.51 $8,800 - $17,550	5,000 Added 1.96%	260,000 $842,000
Q2 2019 Aug 14, 2019	BUY	$1.59 - $2.14 $39,750 - $53,500	25,000 Added 10.87%	255,000 $472,000
Q1 2019 May 15, 2019	BUY	$1.77 - $3.56 $407,100 - $818,800	230,000 New	230,000 $407,000

39.2M

10.3K

200

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $83.1M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Awh Capital, L.P., based on Form 13F filings with the SEC.

Stay updated on Awh Capital, L.P. with notifications on news.